RSAD2 Knockout CNE-2 Cell Line

RSAD2 Knockout CNE-2 Cell Line
Cat.No.:

EDJ-KQ16

Species:

Human

Cell Name:

CNE-2

Gene:

RSAD2

Gene ID:

91543

Size:

1×10⁶cells

RSAD2 Knockout Cell Line (CNE2-EBV) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
Cat.No. EDJ-KQ16
Product Name RSAD2 Knockout Cell Line (CNE2-EBV)
Cell line CNE-2
Cellosaurus ID CVCL_6889
Cell Line Synonyms CNE2
Gene RSAD2
NCBI Gene ID
Gene Synonyms SAND|cig33|cig5|vig1
Summary
The protein encoded by this gene is an interferon-inducible antiviral protein that belongs to the S-adenosyl-L-methionine (SAM) superfamily of enzymes. The protein plays a role in cellular antiviral response and innate immune signaling. Antiviral effects result from inhibition of viral RNA replication, interference in the secretory pathway, binding to viral proteins and dysregulation of cellular lipid metabolism. The protein has been found to inhibit both DNA and RNA viruses, including influenza virus, human immunodeficiency virus (HIV-1) and Zika virus. [provided by RefSeq, Sep 2020]
Morphology Adherent
Passage Ratio 1/3 2 days
Complete Culture Medium 1640+10% FBS
Freezing Medium 55% Complete culture medium + 40% FBS+ 5% DMSO
QC Indels validated by Sanger sequencing; sterility confirmed via microbial testing.
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.

Recommended Accessories

Related Products

Flash CRISPR Knockout Kit(Universal Version)Flash CRISPR Knockout Kit(Universal Version)
Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)

Related Services

Knockout Cell LineKnockout Cell Line
Contact Us
*
*
*
*
How did you hear about us: